Windtree Therapeutics Inc
WINT
WINT was delisted on the 4th of May, 2017.
60 hedge funds and large institutions have $117M invested in Windtree Therapeutics Inc in 2013 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 10 reducing their positions, and 5 closing their positions.
200% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 5
136% more capital invested
Capital invested by funds: $49.7M → $117M (+$67.4M)
130% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 10
20% more funds holding
Funds holding: 50 → 60 (+10)
16% more call options, than puts
Call options by funds: $425K | Put options by funds: $366K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
+$13.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.69M |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$8.21M |
| 4 |
DM
Deerfield Management
New York
|
+$5.52M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$4.91M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$797K |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$310K |
| 3 |
COPM
Charter Oak Partners Management
Westport,
Connecticut
|
-$240K |
| 4 |
D.E. Shaw & Co
New York
|
-$173K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$85.6K |
WINT Hedge Fund Activity: Q4 2013 in Review
60 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q4 2013, worth a combined $117M — up 136% from $49.7M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new WINT positions and 5 closed out — a net gain of 10 holders — while 23 added to existing stakes and 10 trimmed.
The largest buyer was Broadfin Capital, adding an estimated $13.2M. The largest seller was Wells Fargo, cutting an estimated $797K.
- 60 institutional investors held Windtree Therapeutics Inc (WINT) as of Q4 2013, up from 50 in Q3 2013.
- Funds reported $117M of Windtree Therapeutics Inc stock for Q4 2013, up 136% quarter-over-quarter.
- 15 funds opened new Windtree Therapeutics Inc positions in Q4 2013 and 5 closed out, a net change of +10 holders.
- The largest Windtree Therapeutics Inc buyer in Q4 2013 was Broadfin Capital, an estimated $13.2M added.
- The largest Windtree Therapeutics Inc seller in Q4 2013 was Wells Fargo, an estimated $797K sold.
Based on aggregated 13F filings for Q4 2013.